EVGN – evogene ltd. - ordinary shares (US:NASDAQ)

News

Evogene Releases CEO Letter to Shareholders
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com